16th – 18th April, 2018

London, UK

Day One
Tuesday, 17th April, 2018

Day Two
Wednesday, 18th April, 2018

08.45
Chair’s Opening Remarks

  • Daragh Ryan Clinical Trials Technology Consultant, Actelion Pharmaceuticals

09.00
Opening Keynote Panel Discussion: From Start, to Finish – How to Innovate the Conduct of Clinical Studies & Accelerate the Delivery of New Therapies to Patients with Mobile-Enabled Clinical Trials

  • Bryan McDowell Global Program Lead, Digital Development, Novartis
  • Kai Langel Director, R&D Operations Innovation, Janssen Pharmaceuticals
  • Mikael Eliasson Global Head, Strategic Innovation, Roche

Synopsis

• Addressing the rapidly evolving mHealth landscape in pharma, the growing interest and the latest and exciting advances on the use of these technologies to support and drive clinical studies
• Overcoming the operational and regulatory challenges of running mHealth supported clinical trials
• Maximizing patient centricity and innovation, improving trial efficiency and reducing costs – embracing the growing possibilities of mHealth-enabled clinical research to accelerate drug development
• Discussing the role of big tech companies in the future of digital innovation is clinical trials
• Outlining where we are and where we are going – important learnings to date and perspectives on future directions

09.45
Going Digital – Accelerating Clinical Development

Synopsis

• Detailing on Roche’s experiences using digital tools in clinical trials
• Overviewing the promise of meaningful data at scale
• What will “digital 2.0” look like?

10.15
The Cloud & Mobile Clinical Trial: the Experience of an European Digital CRO

Synopsis

  • Presenting the benefits of a digital clinical trial ecosystem including use cases
  • Addressing the development of novel endpoints generated by mobile technology
  • Reviewing the near future horizons in clinical research : the virtual and the intelligent clinical trials

10.45
Speed Networking Session & Morning Refreshments

Patient Centricity – An Evolving Paradigm in Clinical Development

11.45
Right Patient, Right Trial – Leveraging Technology For Recruitment, Enrolment & Consent in Clinical Trials

  • Seleen Ong Clinical Sciences Group Lead & Clinical Program Lead for Clinical Trial Innovation, Pfizer

Synopsis

• Enhancing awareness of trials available
• Refining pre-screening algorithms
• Improving the experience of informed consent for patients

12.15
Promoting the Patient as a Partner & Not a Subject of the Study

  • Tim Cave VP - Head Strategic Planning & Digital Practices, Global Medical Affairs, GlaxoSmithKline

Synopsis

• Supporting patient engagement and involvement across all stages of the clinical trial
• Maximising awareness and sharing of information – enabling easier communication with investigators and sponsors including communication of results

12.45
Elevating Patients to the Centre of Clinical Research – an Innovative Approach

  • Shiyan Caan Marketing & Business Development Coordinator, SQN Clinical

Synopsis

  • Collecting wellness data alongside protocol required data
  • Better understanding a patient and their response to a trial
  • Communication is key
  • Protocol compliance and clinical oversight

12.55
Lunch & Networking

14.00
Accelerating Digital – Overviewing the NIHR Clinical Research Network’s Endeavours To Support the Operational Embedding & Adoption of Digital Across the Research Network, NHS & Industry Partners

  • Anthea Mould Head of AHP/Pharmacy and Continuous Improvement, NIHR Clinical Research Network
  • Jess Radcliffe Improvement and Programme Manager, NIHR Clinical Research Network

Synopsis

• Promoting and developing a focused digital programme at the NIHR CRN
• Enabling and supporting the adoption of digital across commercial and non-commercial studies to maximise patient centricity and involvement in clinical research

14.30
Mastermind Session: Supporting the Successful & Efficient Adoption Of mHealth Solutions Within Clinical Trials

Synopsis

This session facilitates in-depth discussions between participants in an informal
environment. After splitting into small groups, participants will discuss key issues and challenges regarding the implementation of mobile technology in clinical trials.

15.30
Afternoon Refreshments & Networking

16.00
Promoting the Patient as a Partner & Not a Subject of the Study

  • Derek Stewart Associate Director - Patient & Public Involvement, NIHR Clinical Research Network

Synopsis

• Patient advocate view on the role of mHealth in patient-centric clinical research
• Discussing how mobile technology can promote and enhance patient involvement in and awareness of clinical studies

16.30
Panel Discussion: Transforming the Clinical Development Paradigm With Digital Health Innovation

  • Carsten Spannhuth Director, Clinical Project Physician, Idorsia Pharmaceuticals
  • David Goren Strategic Consultant, Epione Strategy, Ltd.
  • Derek Stewart Associate Director - Patient & Public Involvement, NIHR Clinical Research Network
  • Seleen Ong Clinical Sciences Group Lead & Clinical Program Lead for Clinical Trial Innovation, Pfizer

Synopsis

• Embracing the patient as a crucial partner in study design and conduct
• Deploying mHealth technologies and tools to maximize patient centricity in clinical research – from data collection to patient adherence
• Leveraging mHealth approaches for improved trial recruitment and design – promises and challenges

17.15
Chair’s Closing Remarks

  • Daragh Ryan Clinical Trials Technology Consultant, Actelion Pharmaceuticals